Table 2.
Multinomial logistic regression of immune phenotype, immune cell level and tumor cell level in patients with metastatic urothelial cancer
| Gene | Immunophenotype | ||||
|
| |||||
| Desert | Excluded | Inflamed | |||
|
|
|
||||
| OR (95% CI) | P Value | OR (95% CI) | P Value | ||
|
| |||||
| CXCL9 | Reference | 1.209 (0.727, 2.009) | 0.465 | 1.314 (0.728, 2.373) | 0.364 |
| GBP5 | 2.594 (1.469, 4.581) | 0.001 | 5.938 (2.868, 12.295) | < 0.001 | |
| IFNG | 0.217 (0.009, 5.137) | 0.344 | 1.309 (0.047, 36.181) | 0.874 | |
|
| |||||
| Immune cell level | |||||
|
|
|||||
| IC0 | IC1 | IC2+ | |||
|
|
|
||||
| OR (95% CI) | P Value | OR (95% CI) | P Value | ||
|
| |||||
| CXCL9 | Reference | 0.935 (0.581, 1.505) | 0.781 | 1.984 (1.193, 3.301) | 0.008 |
| GBP5 | 2.740 (1.656, 4.534) | < 0.001 | 2.403 (1.357, 4.255) | 0.003 | |
| IFNG | 1.030 (0.054, 19.642) | 0.984 | 1.368 (0.069, 26.927) | 0.837 | |
|
| |||||
| Tumor cell level | |||||
|
|
|||||
| TC0 | TC1 | TC2+ | |||
|
|
|
||||
| OR (95% CI) | P Value | OR (95% CI) | P Value | ||
|
| |||||
| CXCL9 | Reference | 1.242 (0.700, 2.203) | 0.459 | 1.036 (0.725, 1.480) | 0.848 |
| GBP5 | 0.638 (0.312, 1.304) | 0.218 | 2.033 (1.294, 3,195) | 0.002 | |
| IFNG | 7.498 (1.279, 43.954) | 0.026 | 1.377 (0.369, 5.148) | 0.634 | |